Your browser doesn't support javascript.
loading
Countering COVID-19 Vaccine Hesitancy in Pregnancy: the "4 Cs".
Shook, Lydia L; Kishkovich, Thomas P; Edlow, Andrea G.
Afiliação
  • Shook LL; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Kishkovich TP; Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, Massachusetts.
  • Edlow AG; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Am J Perinatol ; 39(10): 1048-1054, 2022 07.
Article em En | MEDLINE | ID: mdl-34666378
Despite evidence to support the safety and efficacy of COVID-19 vaccination in pregnancy, and clear recommendations from professional organizations and the Centers for Disease Control and Prevention (CDC) for pregnant people to get vaccinated, COVID-19 vaccine hesitancy in pregnancy remains a significant public health problem. The emergence of the highly transmissible B.1.617.2 (Delta) variant among primarily unvaccinated people has exposed the cost of vaccine hesitancy. In this commentary, we explore factors contributing to COVID-19 vaccine hesitancy in pregnancy and potential solutions to overcome them. KEY POINTS: · Low COVID-19 vaccination coverage in pregnant people is a major public health problem in the United States.. · COVID-19 vaccine hesitancy in pregnancy is multifactorial.. · The "4 Cs" framework may be useful in countering COVID-19 vaccine hesitancy..
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / COVID-19 Limite: Female / Humans / Pregnancy País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / COVID-19 Limite: Female / Humans / Pregnancy País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article